Ausgabe 11/2014
Inhalt (19 Artikel)
Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology
Alessandro Di Cerbo, Beniamino Palmieri, Gionata De Vico, Tommaso Iannitti
Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity
Yuli Li, Guobo Shen, Wen Nie, Zhimian Li, Yaxiong Sang, Binglan Zhang, Yuquan Wei
Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke
Matjaz Vogelsang, Juliano D. Paccez, Georgia Schäfer, Kevin Dzobo, Luiz F. Zerbini, M. Iqbal Parker
Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression
Feng Huang, Mei Wang, Tingting Yang, Jie Cai, Qiang Zhang, Zixuan Sun, Xiaodan Wu, Xu Zhang, Wei Zhu, Hui Qian, Wenrong Xu
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
Kirill Litovkin, Steven Joniau, Evelyne Lerut, Annouschka Laenen, Olivier Gevaert, Martin Spahn, Burkhard Kneitz, Sofie Isebaert, Karin Haustermans, Monique Beullens, Aleyde Van Eynde, Mathieu Bollen
The BRAF mutation is associated with the prognosis in colorectal cancer
Tae Sung Ahn, Dongjun Jeong, Myoung Won Son, Haeil Jung, Soyoung Park, Hyungjoo Kim, Sang Byung Bae, Han Jo Kim, Young-Woo Jeon, Moon Soo Lee, Moo-Jun Baek
Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events
Carolin Bock, Christina Kuhn, Nina Ditsch, Regina Krebold, Sabine Heublein, Doris Mayr, Sophie Doisneau-Sixou, Udo Jeschke
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO
Anle Zhang, Yuanhong Zheng, Zujun Que, Lingling Zhang, Shengchao Lin, Vanminh Le, Jianwen Liu, Jianhui Tian
LASP-1 promotes tumor proliferation and metastasis and is an independent unfavorable prognostic factor in gastric cancer
Jie Zheng, Shuna Yu, Yanchun Qiao, Hongxia Zhang, Shujuan Liang, Hailiang Wang, Yuqing Liu, Fenghua Zhou, Jiying Jiang, Shijun Lu
Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
Huan Wang, Jing Huang, Xiaojin Yu, Shuhua Han, Xing Yan, Siqing Sun, Xiaoli Zhu
Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
Huan Wang, Jing Huang, Xiaojin Yu, Shuhua Han, Xing Yan, Siqing Sun, Xiaoli Zhu
Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients
Kai Zhang, Tienian Zhu, Dongmei Gao, Yimei Zhang, Qinglan Zhao, Shuang Liu, Tongyi Su, Michel Bernier, Ruijing Zhao
Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response—a retrospective study
Yuan-Hao Yang, Jen-Kou Lin, Wei-Shone Chen, Tzu-Chen Lin, Shung-Haur Yang, Jeng-Kai Jiang, Yuan-Tzu Lan, Chun-Chi Lin, Chueh-Chuan Yen, Cheng-Hwai Tzeng, Hao-Wei Teng
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy
Marta Scorsetti, Piera Navarria, Fiorenza De Rose, AnnaMaria Ascolese, Elena Clerici, Ciro Franzese, Francesca Lobefalo, Giacomo Reggiori, Pietro Mancosu, Stefano Tomatis, Antonella Fogliata, Luca Cozzi
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma
Wolfram Pönisch, Bruno Holzvogt, Madlen Plötze, Marc Andrea, Malvina Bourgeois, Simone Heyn, Thomas Zehrfeld, Doreen Hammerschmidt, Maik Schwarz, Thomas Edelmann, Cornelia Becker, Franz Albert Hoffmann, Andreas Schwarzer, Ute Kreibich, Kerstin Gutsche, Kolja Reifenrath, Cornelia Winkelmann, Rainer Krahl, Yvonne Remane, Evelin Hennig, Thomas Schliwa, Tom Lindner, Thorsten Kaiser, Vladan Vucinic, Gerhard Behre, Dietger Niederwieser
A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET
Mitsunori Higuchi, Hiroshi Honjo, Takeshi Shigihara, Fumio Shishido, Hiroyuki Suzuki, Mitsukazu Gotoh
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase
Michael Lauseker, Benjamin Hanfstein, Claudia Haferlach, Susanne Schnittger, Markus Pfirrmann, Alice Fabarius, Brigitte Schlegelberger, Susanne Saußele, Christian T. Dietz, Philipp Erben, Rüdiger Hehlmann, Joerg Hasford, Andreas Hochhaus, Martin C. Müller
Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD
Angela Mensen, Il-Kang Na, Ralf Häfer, Astrid Meerbach, Maria Schlecht, Marie-Luise Pietschmann, Bernd Gruhn
Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-CI
Christian Späth, Christoph Busemann, William H. Krüger